AstraZeneca profit climbs on cancer and heart drug demand

Core Insights - The pharmaceutical giant reported profits that met expectations and revenue that slightly exceeded forecasts on Tuesday [1] Financial Performance - Profit was in line with market expectations [1] - Revenue slightly beat forecasts [1]